Enamine Ltd. and UkrOrgSynthesis Ltd have announced they have signed a collaboration agreement to offer chemical building blocks to the drug discovery industry.
By combining their catalogues, the companies become the largest global manufacturer and seller of building blocks, with 60,000 products available from stock for immediate delivery and an array of ca. 8 million tangible building blocks deliverable at fixed prices within 4-6 weeks, with synthetic success rate of 80%.
According to the terms of the agreement, UORSY products are now obtainable through Enamine, and up-to-date catalogues of in-stock and tangible building blocks from both companies are available from both Enamine and UORSY.
Enamine is now able to act as a single point of contact for requests from both catalogues, at no extra cost to customers.
Enamine and UORSY have received many requests over the years for building blocks from both in-stock and tangible collections from a wide range of pharmaceutical, agrochemical, cosmetic, and nutraceutical companies, and academic research institutions, in a continuously growing trend.
Michael Bossert, Business Development Director, said “We are confident that the collaboration extension will enable us to offer enhanced customer service, and improve the day-to-day selection, ordering and purchasing process for clients. We hope that this will result in a significant increase in market share for both Enamine and UORSY.”
He continued, “Enamine and UORSY have been working together in the design of building blocks for several years, and the extension of the collaboration for provision of logistical support from Enamine is a natural step in the business relationship.”